Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.

Publication ,  Journal Article
Samoylova, ML; Dodge, JL; Yao, FY; Roberts, JP
Published in: Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
August 2014

In the United States, there are significant geographic disparities in the time to transplantation for patients with hepatocellular carcinoma (HCC); it is possible that rapid transplantation contributes to higher rates of posttransplant HCC recurrence because there is insufficient time for the tumor biology to manifest. In this study, we compared HCC recurrence in rapid transplant patients and their slower transplant counterparts. We identified adult liver transplantation (LT) candidates in the Organ Procurement and Transplantation Network/United Network for Organ Sharing (UNOS) data set who were granted an initial exception for an HCC diagnosis between January 1, 2006 and September 30, 2010 and underwent transplantation in the same time window. Patients were followed until HCC recurrence, non-HCC-related death, or last follow-up. The cumulative incidence of HCC recurrence was compared for patients waiting ≤ 120 days and patients waiting >120 days from an HCC exception to LT. The association between the risk of posttransplant recurrence and the wait time was further evaluated via competing risks regression with the Fine and Gray model. For 5002 LT recipients with HCC, the median wait time from an exception to LT was 77 days, and it varied from 30 to 169 days by UNOS region. The cumulative incidence of posttransplant HCC recurrence was 3.3% [95% confidence interval (CI) = 2.8%-3.8%] and 5.6% (95% CI = 5.0%-6.3%) within 1 and 2 years, respectively. The rate of observed recurrence within 1 year of transplantation was significantly lower for patients waiting >120 days versus patients waiting ≤ 120 days (2.2% versus 3.9%, P = 0.002); however, the difference did not persist at 2 years (5.0% versus 5.9%, P = 0.09). After we accounted for clinical factors, the HCC recurrence risk was reduced by 40% for patients waiting >120 days (subhazard ratio = 0.6, P = 0.005). In conclusion, the risk of HCC recurrence within the first year after transplantation may be lessened by the institution of a mandatory waiting time after an exception is granted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

DOI

EISSN

1527-6473

ISSN

1527-6465

Publication Date

August 2014

Volume

20

Issue

8

Start / End Page

937 / 944

Related Subject Headings

  • Waiting Lists
  • Treatment Outcome
  • Tissue and Organ Procurement
  • Time-to-Treatment
  • Time Factors
  • Surgery
  • Recurrence
  • Neoplasm Recurrence, Local
  • Neoplasm Metastasis
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samoylova, M. L., Dodge, J. L., Yao, F. Y., & Roberts, J. P. (2014). Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 20(8), 937–944. https://doi.org/10.1002/lt.23902
Samoylova, Mariya L., Jennifer L. Dodge, Francis Y. Yao, and John Paul Roberts. “Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20, no. 8 (August 2014): 937–44. https://doi.org/10.1002/lt.23902.
Samoylova ML, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2014 Aug;20(8):937–44.
Samoylova, Mariya L., et al. “Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol. 20, no. 8, Aug. 2014, pp. 937–44. Epmc, doi:10.1002/lt.23902.
Samoylova ML, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2014 Aug;20(8):937–944.
Journal cover image

Published In

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

DOI

EISSN

1527-6473

ISSN

1527-6465

Publication Date

August 2014

Volume

20

Issue

8

Start / End Page

937 / 944

Related Subject Headings

  • Waiting Lists
  • Treatment Outcome
  • Tissue and Organ Procurement
  • Time-to-Treatment
  • Time Factors
  • Surgery
  • Recurrence
  • Neoplasm Recurrence, Local
  • Neoplasm Metastasis
  • Middle Aged